Globe iconLogin iconRecap iconSearch iconTickets icon

D-backs' Dezzi, White Sox's Loe suspended

Hillsboro outfielder, 2015 draftee, tests positive for amphetamines
5:13 PM EDT

NEW YORK -- D-backs Minor Leaguer Stephen Dezzi and White Sox pitcher Kameron Loe were suspended on Tuesday after both tested positive for banned substances.

The Office of the Commissioner of Baseball said Dezzi received a 50-game suspension without pay following a positive test for an amphetamine, a stimulant in violation of the Minor League Drug Prevention and Treatment Program. 

Loe received an 80-game suspension without pay following a positive test for Dehydrochlormethyltestosterone metabolite and Methasterone, both performance-enhancing substances according to MLB.

Dezzi's suspension will be effective at the start of the 2016 Northwest League season in June, while Loe will begin serving his on Opening Day, April 7, MLB said.

Dezzi, 23, was Arizona's 25th-round pick in the 2015 Draft out of the University of Tampa. He appeared in 48 games for Class A Short Season Hillsboro last summer, hitting .208 with a pair of home runs, 15 RBIs, 24 walks, 10 doubles and 25 runs scored in 149 at-bats.

Loe, 34, hasn't pitched since 2014, when he saw time at Triple-A with the Royals, Braves and D-backs. He received a 50-game suspension from MLB last Jan. 15 for a second positive test for a drug of abuse. The veteran righty has appeared in 322 career Major League games.

Amphetamines are considered a stimulant and a performance-enhancing substance by the Major League Baseball's Joint Drug Prevention and Treatment Program. Minor Leaguers who test positive for PEDs are subject to a 50-game suspension upon their first violation.

Dehydrochlormethyltestosterone, an anabolic steroid, is a Schedule III controlled substance in the U.S. and among the World Anti-Doping Agency's prohibited substances. It's believed to aid in gaining speed and strength.

Major League Baseball has suspended 29 players this year for violating the Minor League drug program.

Danny Wild is an editor for MiLB.com. Follow his MLBlog column, Minoring in Twitter.